ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Drug Development

Drug Development

(©TimMasters/Shutterstock.com)

The FDA has nixed Eli Lilly's and Inctye's application for baricitinib in its current form asking for additional safety and clinical data.

HFF Rituxan 500mg (©Genentech)

Designated a breakthrough therapy for pemphigus vulgaris, rituximab has been shown to work better than prednisone alone and with fewer adverse events, researchers report in The Lancet.

(©Zonda/Shutterstock.com)

In this slideshow, we summarize the newly approved indications for Amgen's new biosimilar, adalimumab-atto (Amjevita) and, we highlight key points as stated by Amgen researchers.

©LipowskiMilan/Shutterstock.com

Ixekizumab, one of three anti-IL-17 agents for moderate-to-severe plaque psoriasis, has been approved by the FDA for plaque psoriasis — a disease that goes untreated for most patients.

Subscribe to Drug Development on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.